Humoral and cell-mediated immune responses elicited by poly (dl-lactide) adjuvanted filarial antigen molecules

References

• Babayan SA, Attout T, Harris A, et al. (2006). Vaccination against filarial nematodes with irradiated larvae provides long-term protection against the third larval stage but not against subsequent life cycle stages. Int J Parasitol 36:903–14
   PubMed Web of Science ®Google Scholar
• Babu S, Blauvelt CP, Kumaraswami V, et al. (2005). Diminished expression and function of TLR in lymphatic filariasis: a novel mechanism of immune dysregulation. J Immunol 175:1170–6
   PubMed Web of Science ®Google Scholar
• Bal M, Das MK. (1999). Antibody response to a filarial antigen fraction in individuals exposed to Wuchereria bancrofti infection in India. Acta Trop 72:259–74
   PubMed Web of Science ®Google Scholar
• Chandrashekar R, Rao UR, Parab PB, et al. (1985). Brugia malayi: serum dependent cell-mediated reactions to microfilariae. Southeast Asian J Trop Med Public Health 16:15–21
   PubMedGoogle Scholar
• Chandrashekar R, Rao UR, Subrahmanyam D. (1990). Antibody-mediated cytotoxic effects in vitro and in vivo of rat cells on infective larvae of Brugia malayi. Int J Parasitol 20:725–30
   PubMed Web of Science ®Google Scholar
• Chesko J, Kazzaz J, Ugozzoli M, et al. (2005). An investigation of the factors controlling the adsorption of protein antigens to anionic PLG microparticles. J Pharm Sci 94:2510–19
   PubMed Web of Science ®Google Scholar
• Dimock KA, Eberhard ML, Lammie PJ. (1996). Th1-like antifilarial immune responses predominate in antigen-negative persons. Infect Immun 64:2962–7
   PubMed Web of Science ®Google Scholar
• Dixit S, Gaur RL, Khan MA, et al. (2004). Inflammatory antigens of Brugia malayi and their effect on rodent host Mastomys coucha. Parasite Immunol 26:397–407
   PubMed Web of Science ®Google Scholar
• Dixit S, Gaur RL, Sahoo MK, et al. (2006). Protection against L3 induced Brugia malayi infection in Mastomys coucha preimmunized with BmAFII fraction of the filarial adult worm. Vaccine 24:5824–31
   PubMed Web of Science ®Google Scholar
• El Bouhdidi A, Truyens C, Rivera MT, et al. (1994). El Bouhdidi A, Bazin H, Carlier Y. Trypanosoma cruzi infection in mice induces a polyisotypic hypergamma-globulinaemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies. Parasite Immunol 16:69–76
   PubMed Web of Science ®Google Scholar
• Elson LH, Calvopina M, Paredes W, et al. (1995). Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. J Infect Dis 171:652–8
   PubMed Web of Science ®Google Scholar
• Furchgott RF. (1999). Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Biosci Rep 19:235–51
   PubMed Web of Science ®Google Scholar
• Gillan V, Devaney E. (2005). Regulatory T cells modulate Th2 responses induced by Brugia pahangi third-stage larvae. Infect Immun 73:4034–42
   PubMed Web of Science ®Google Scholar
• Gregory WF, Atmadja AK, Allen JE, et al. (2000). The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Infect Immun 68:4174–9
   PubMed Web of Science ®Google Scholar
• Joseph SK, Verma SK, Sahoo MK, et al. (2011). Sensitization with anti-inflammatory BmAFI of Brugia malayi allows L3 development in the hostile peritoneal cavity of Mastomys coucha. Acta Trop 120:191–205
   PubMed Web of Science ®Google Scholar
• Joseph SK, Sambanthamoorthy S, Dakshinamoorthy G, et al. (2012). Protective immune responses to biolistic DNA vaccination of Brugia malayi abundant larval transcript-2. Vaccine 30:6477–82
   PubMed Web of Science ®Google Scholar
• Kanai N, Min WP, Ichim TE, et al. (2007). Th1/Th2 Xenogenic antibody responses are associated with recipient dendritic cells. Microsurgery 27:234–9
   PubMed Web of Science ®Google Scholar
• Klei TR, McVay CS, Dennis VA, et al. (1990). Brugia pahangi: effects of duration of infection and parasite burden on lymphatic lesion severity, granulomatous hypersensitivity, and immune responses in jirds (Meriones unguiculatus). Exp Parasitol 71:393–405
   PubMed Web of Science ®Google Scholar
• Krithika KN, Dabir P, Kulkarni S, et al. (2005). Identification of 38 kDa Brugia malayi microfilarial protease as a vaccine candidate for lymphatic filariasis. Indian J Exp Biol 43:759–68
   PubMedGoogle Scholar
• Liew FY. (1995). Nitric oxide in infectious and autoimmune diseases. Ciba Found Symp 195:234–39
   PubMedGoogle Scholar
• Maizels RM, Balic A, Gomez-Escobar N, et al. (2004). Helminth parasites-masters of regulation. Immunol Rev 201:89–116
   PubMed Web of Science ®Google Scholar
• Maizels RM, Lawrence RA. (1991). Immunological tolerance: the key feature in human filariasis? Parasitol Today 7:271–6
   PubMedGoogle Scholar
• Misra S, Singh DP, Murthy PK, Chatterjee RK. (1990). Mode of action of antifilarials: modulation of immune adherence to microfilariae in vitro. Trop Med 32:3233–43
   Google Scholar
• Murthy PK, Dennis VA, Lasater BL, et al. (2000). Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins. Infect Immun 68:6663–9
   PubMed Web of Science ®Google Scholar
• Murthy PK, Joseph SK, Abbas M, et al. (2009). Pathobiology of lymphatic filariasis: Understanding at molecular level. Proc Nat Acad Sci India 79:177–94
   Google Scholar
• Murthy PK, Murthy PS, Tyagi K, et al. (1997). Fate of infective larvae of Brugia malayi in the peritoneal cavity of Mastomys natalensis and Meriones unguiculatus. Folia Parasitol 44:302–4
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Singh M, Dong C, et al. (2004). Cationic microparticles are a potent delivery system for a HCV DNA vaccine. Vaccine 23:672–80
   PubMed Web of Science ®Google Scholar
• Oster CG, Kim N, Grode L, et al. (2005). Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination. J Control Release 104:359–77
   PubMed Web of Science ®Google Scholar
• Ottesen EA, Weller PF, Heck L. (1997). Specific cellular immune unresponsiveness in human filariasis. Immunology 33:413–21
   Google Scholar
• Petrovsky N, Aguilar JC. (2004). Vaccine adjuvants: current state and future trends. Immunol Cell Biol 82:488–96
   PubMed Web of Science ®Google Scholar
• Pulendran B, Smith JL, Caspary G, et al. (1999). Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 96:1036–40
   PubMed Web of Science ®Google Scholar
• Rajan TV, Porte P, Yates JA, et al. (1996). Role of nitric oxide in host defense against an extracellular, metazoan parasite, Brugia malayi. Infect Immun 15:619–23
   Google Scholar
• Ramachandran S, Kumar MP, Rami RM, et al. (2004). The larval specific lymphatic filarial ALT-2: induction of protection using protein or DNA vaccination. Microbiol Immunol 48:945–55
   PubMed Web of Science ®Google Scholar
• Sahoo MK, Sisodia BS, Dixit S, et al. (2009). Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection. Vaccine 27:4263–71
   PubMed Web of Science ®Google Scholar
• Saini V, Jain V, Sudheesh MS, et al. (2010). Humoral and cell-mediated immune-responses after administration of a single-shot recombinant hepatitis B surface antigen vaccine formulated with cationic poly(l-lactide) microspheres. J Drug Targeting 18:212–22
   PubMed Web of Science ®Google Scholar
• Saini V, Jain V, Sudheesh MS, et al. (2011a). Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen. Int J Pharm 408:50–7
   PubMed Web of Science ®Google Scholar
• Saini V, Sahoo MK, Murthy PK, et al. (2009). Polymeric lamellar substrate particles as carrier adjuvant for recombinant hepatitis B surface antigen vaccine. Vaccine 27:2372–8
   PubMed Web of Science ®Google Scholar
• Saini V, Verma SK, Murthy PK, et al. (2013). Poly(d,l)-lactide-co-glycolide (PLGA) microspheres as immunoadjuvant for Brugia malayi antigens. Vaccine 31:4183–91
   PubMed Web of Science ®Google Scholar
• Saini V, Verma SK, Sahoo MK. (2011b). Sufficiency of a single administration of filarial antigens adsorbed on polymeric lamellar substrate particles of poly (L-lactide) for immunization. Int J Pharm 420:101–10
   PubMedGoogle Scholar
• Schmidt CS, Morrow WJ, Sheikh NA. (2007). Smart adjuvants. Expert Rev Vaccin 6:391–400
   PubMed Web of Science ®Google Scholar
• Shakya S, Kumar Singh P, Kushwaha S, et al. (2009). Adult Brugia malayi approximately 34 kDa (BMT-5) antigen offers Th1 mediated significant protection against infective larval challenge in Mastomys coucha. Parasitol Int 58:346–53
   PubMed Web of Science ®Google Scholar
• Singh M, Briones M, Ott G, et al. (2000). Cationic microparticles. A potent delivery system for DNA vaccines. Proc Nat Acad Sci 97:811–6
   PubMed Web of Science ®Google Scholar
• Stivaktakis N, Nikou K, Panagi Z, et al. (2005). Immune responses in mice of b-galactosidase adsorbed or encapsulated in poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. Wiley Periodical Inc 73:332--8
   Google Scholar
• Taylor MJ, Cross HF, Mohammed AA, et al. (1996). Susceptibility of Brugia malayi and Onchocerca lienalis microfilariae to nitric oxide and hydrogen peroxide in cell-free culture and from IFN-γ activated macrophages. Parasitology 112:315–22
   PubMed Web of Science ®Google Scholar
• Thomas GR, McCrossan M, Selkirk ME. (1997). Cytostatic and cytotoxic effects of activated macrophages and nitric oxide donors on Brugia malayi. Infect Immun 65:2732–9
   PubMed Web of Science ®Google Scholar
• Vedi S, Dangi A, Hajela K, et al. (2008). Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models. Vaccine 26:5997–05
   PubMed Web of Science ®Google Scholar
• Vordermeier HM, Coombes AGA, Jenkins P, et al. (1995). Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine 13:1576–82
   PubMed Web of Science ®Google Scholar
• WHO. (2005). Global programme to eliminate lymphatic filariasis. Wkly Epidemiol Rec 80:202–12
   PubMedGoogle Scholar
• Zeldenryk LM, Gray M, Speare R, et al. (2011). The emerging story of disability associated with lymphatic filariasis: a critical review. PLoS Negl Trop Dis 5:e1366
   PubMed Web of Science ®Google Scholar